Global product launch of Blue Medical’s CE approved DEB Protégé and CoCr on DEB Pioneer
Blue Medical today announced the global product launch of its CE approved drug eluting balloon (DEB) Protégé as well as its CoCr stent on DEB Pioneer.
The full market launch of the new DEB technology is a major step forward in Blue Medical’s quest to improve the quality of life of patients with cardiovascular diseases, while at the same time reducing procedure costs.
Cardiovascular disease, facts and figures
A common disease in the Modern World
Claiming more lives than the next five causes of death combined. The demographic shift towards an older population together with life-style factors, will result in a continual increase in the number of people in need of a cardiovascular revascularization.
Our Vision
Relief to the heart and peace of mind
Blue Medical strives to improve the quality of life of patients with cardiovascular disease by developing superior and innovative therapeutic devices for minimally invasive interventions.
Our Mission
New generations of drug-eluting products
Blue Medical is continually exploring new paths to improve the treatment of cardiovascular disease. Innovation by investigating new drugs for improved vascular healing, ensuring biocompatible, safe and controllable elution solutions, but also by optimizing device platforms for the highest degree of performance. All our work is carried out in partnership with leading physicians. Protégé our evidenced based Paclitaxel Eluting balloon and its sibling Pioneer, proven CoCr stent mounted on a Paclitaxel eluting balloon are the latest leading products to further enhance patient care.
Our Team
Dedication and Passion to success
Blue Medical's team of enthusiastic highly experienced people work closely together in our two facilities with eleven clean rooms to ensure a high volume of high quality coronary products. Our organization with multi disciplined teams enables flexibility and quick decision making to deliver innovative performing results for our customers and their patients.
